Patents by Inventor Meinoshin Okumura

Meinoshin Okumura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medicinal agent for preventing exacerbation of malignant tumor, comprising combination of natriuretic peptide receptor GC-A and GC-B agonists
    Patent number: 9233143
    Abstract: Provided are a medicinal agent which is highly safe for use as the treatment of a malignant tumor and is capable of efficiently treating a malignant tumor, that is, a medicinal agent for treating a malignant tumor or for suppressing or preventing the exacerbation thereof, comprising at least one kind of natriuretic peptide receptor GC-A agonist and at least one kind of natriuretic peptide receptor GC-B agonist to be administered in combination; a therapeutic method comprising administering the agent; etc.
    Type: Grant
    Filed: August 17, 2012
    Date of Patent: January 12, 2016
    Assignees: National Cerebral and Cardiovascular Center, Osaka University, Shionogi & Co., Ltd.
    Inventors: Kenji Kangawa, Hiroshi Hosoda, Takashi Nojiri, Meinoshin Okumura, Mayumi Furuya
  • MEDICINAL AGENT FOR PREVENTING EXACERBATION OF MALIGNANT TUMOR, COMPRISING COMBINATION OF NATRIURETIC PEPTIDE RECEPTOR GC-A AND GC-B AGONISTS
    Publication number: 20140248269
    Abstract: Provided are a medicinal agent which is highly safe for use as the treatment of a malignant tumor and is capable of efficiently treating a malignant tumor, that is, a medicinal agent for treating a malignant tumor or for suppressing or preventing the exacerbation thereof, comprising at least one kind of natriuretic peptide receptor GC-A agonist and at least one kind of natriuretic peptide receptor GC-B agonist to be administered in combination; a therapeutic method comprising administering the agent; etc.
    Type: Application
    Filed: August 17, 2012
    Publication date: September 4, 2014
    Applicants: NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER, DAIICHI SANKYO COMPANY, LIMITED, OSAKA UNIVERSITY
    Inventors: Kenji Kangawa, Hiroshi Hosada, Takashi Nojiri, Meinoshin Okumura, Mayumi Furuya
  • MEDICINAL AGENT FOR SUPPRESSING MALIGNANT TUMOR METASTASIS
    Publication number: 20140072557
    Abstract: A medicinal agent for suppressing or preventing the metastasis of a malignant tumor, the agent comprising, as an active ingredient, at least one kind of vascular endothelial intracellular cGMP enhancer.
    Type: Application
    Filed: February 27, 2012
    Publication date: March 13, 2014
    Applicants: NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER, DAIICHI SANKYO COMPANY, LIMITED, OSAKA UNIVERSITY
    Inventors: Kenji Kangawa, Hiroshi Hosada, Takashi Nojiri, Meinoshin Okumura